Chlorpropamide to be discontinued in Canada before mid-2017Patients taking chlorpropamide must be switched to an alternate therapy for type 2 diabetes. Canadian Diabetes Association recognizes cardiovascular benefits of liraglutideRevised interim statement includes liraglutide as an option for adults with type 2 diabetes and clinical cardiovascular disease. Artificial intelligence screens for diabetic retinopathy Google scientists say ‘deep learning’ algorithm has high sensitivity and specificity Some SGLT2 inhibitors increase risk of loss of bone mineral density and fracture Rare side effect reported with canagliflozin, and with dapagliflozin in patients with moderate renal impairment. $1 million commitment to improve wellness around the globe through diabetes prevention and management A cost-cutting success story: Limiting test-strip reimbursement does not harm diabetes patients Ontario decision saved millions without worsening rates of dysglycemia, study finds Yogurt may play key role in diabetes prevention Canadian researcher Shirin Panahi sheds light on this potential superfood Diabetes international press review – October 26, 2016 Sleep-deprived preschoolers likely to eat too much Cholesterol-lowering meds to increase diabetes risk? First Previous 32 33 34 35 36 Next Last
